Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 1:11 AM
NCT ID:
NCT05644093
Brief Summary:
The goal of this clinical trial is to test SPL026 given via injection into a muscle in healthy volunteers.
Detailed Description:
Part A: Crossover IM then IV dosing with SPL026 in psychedelic experienced, healthy volunteers.
PART B: IM dosing only with SPL026 in less experienced/psychedelic naive, healthy volunteers.
Study:
NCT05644093
Study Brief:
Protocol Section:
NCT05644093